FTC - First Trust Large Cap Growth AlphaDEX Fund

Executive Summary

First Trust Large Cap Growth AlphaDEX Fund (FTC) is a US-listed exchange-traded fund sponsored by First Trust Portfolios that seeks to replicate the performance of the S&P 500 AlphaDEX Growth Index by applying a quantitative factor screening methodology to large-cap US equities with growth characteristics. The fund sits within First Trust's broader AlphaDEX ETF family, which includes value and core variants, and is positioned as a factor-tilted alternative to cap-weighted S&P 500 growth products rather than as a market-cap benchmark tracker. As at 8 August 2026, FTC trades at USD183.93, close to its 52-week high of USD194.18 and well above its 52-week low of USD147.94, indicating that the growth factor has already reasserted leadership over the past twelve months.

The investment case rests on continued dominance of the growth factor within large-cap US equities, supported by an underlying momentum tailwind that has already driven FTC to 12-month highs. The key near-term catalyst, evidenced by the May 2026 new 12-month high print, is the persistence of favourable factor conditions into the second half of 2026, with the fund's semi-annual index rebalance offering a discrete timing window for performance re-rating. The primary risk is a rapid factor rotation away from growth and towards value, a regime change explicitly flagged in the fund's own disclosures as capable of producing swift underperformance relative to the broader S&P 500. The thesis is therefore entirely soft in nature, dependent on macro and momentum inputs rather than on any hard catalyst such as an index inclusion, contract win, or corporate event.

OPPORTUNISTIC BUY. Conviction Score: 59/100. The view would be upgraded to a higher conviction on evidence of accelerating earnings momentum in the underlying AlphaDEX roster, and would be downgraded to HOLD if the value factor demonstrably took leadership over a rolling three-month window.

Business Model

FTC generates revenue for its sponsor, First Trust Portfolios, through a single line: the accrual of an expense ratio on assets under management. The fund itself does not generate operating profit in the conventional sense; it is a pooled investment vehicle that collects a management fee, expressed as an expense ratio, levied against average net assets. Based on First Trust's current published fee schedules for the AlphaDEX range, the expense ratio sits in the 0.60% to 0.70% band, broadly comparable to other factor-tilted large-cap ETFs but above plain-vanilla S&P 500 trackers such as those tracking the cap-weighted index. Revenue therefore scales linearly with AUM, making net inflows the principal driver of top-line growth for the product.

The customer base is institutional and retail asset allocators seeking growth-tilted large-cap US equity exposure with a quantitative ranking overlay rather than a passive market-cap weighting. End investors include financial advisers constructing factor-aware model portfolios, registered investment advisers using AlphaDEX mandates for tax-aware or factor-aware sleeves, and retail buyers accessing the fund through brokerage platforms. Distribution is supported by First Trust's longstanding wholesaling relationships across the US adviser channel, which is the primary route to market for the AlphaDEX product family.

The competitive moat is methodological rather than scale-based. The AlphaDEX selection screen combines price momentum, earnings growth momentum, return on equity, and a management-change signal into a single composite ranking, producing a portfolio whose sector and constituent weights can diverge materially from the cap-weighted S&P 500. This differentiated methodology, combined with First Trust's brand recognition within the factor-ETF segment, provides a defensible niche. The flip side is higher portfolio turnover relative to passive trackers, because the semi-annual reconstitution methodology generates more trading activity, which is relevant to the holding-cost profile for buy-and-hold investors.

Financial Snapshot

Recent Catalysts

[5 May 2026] - FTC reached a new 12-month high, with press coverage explicitly comparing the price action to the 52-week range and asking whether the momentum could extend. Source: Daily Political.

[1 May 2026] - WIN Advisors disclosed a reduction of its stake in FTC by an estimated USD10.6 million, selling 65,497 shares of the fund in a transaction flagged by aggregator coverage of the regulatory filing. Source: The Motley Fool (covering an SEC-filed holdings change).

[7 May 2026] - Yahoo Finance published the latest trailing return data set for FTC, confirming the fund's price level and the AlphaDEX methodology language drawn from the fund's official summary prospectus. Source: Yahoo Finance.

[April 2026] - Yahoo Finance published the latest available trailing returns for the AlphaDEX large-cap product family, including FTC, FEX and FTA, providing a cross-reference point for relative performance across the growth, core and value variants. Source: Yahoo Finance.

[5 May 2026] - ETF.com hosted the published holdings, news and quote page for FTC, providing an updated reference for fund operations and benchmark language. Source: ETF.com.

Thesis Evaluation

Key Risks

1. Growth-to-value factor rotation: A rapid regime shift away from growth leadership, explicitly disclosed as a risk for AlphaDEX products, could produce a sharp drawdown relative to the cap-weighted S&P 500. Estimated probability: 35%. Impact: severe.
2. Interest rate sensitivity: Growth factor ETFs are highly sensitive to real yields, and a renewed rise in long-dated US Treasury yields could compress valuations across the underlying growth roster. Estimated probability: 30%. Impact: severe.
3. Institutional outflow risk: WIN Advisors cut its FTC stake by an estimated USD10.6 million in early May 2026, and further reductions by large holders could pressure the price independently of fundamentals. Estimated probability: 20%. Impact: moderate.
4. Methodological concentration: The AlphaDEX screen combines momentum, earnings growth and management-change signals, which can produce concentrated sector or factor exposures that diverge sharply from the labelled benchmark. Estimated probability: 25%. Impact: moderate.
5. Expense ratio drag: The fund's expense ratio in the 0.60% to 0.70% range creates a structural headwind against cheaper cap-weighted S&P 500 growth trackers, compounding over multi-year holding periods. Estimated probability: 100%. Impact: low.
6. Index methodology change: First Trust retains discretion over the AlphaDEX methodology, and any material change to the screening criteria or rebalancing cadence could alter the fund's risk and return profile. Estimated probability: 5%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: Growth-tilted US equity investors with a holding period of at least three to five years who accept factor-rotation risk and want a quantitative, semi-annually rebalanced alternative to cap-weighted S&P 500 growth. The position is appropriate for portfolios where FTC serves as a satellite growth sleeve at no more than 5% to 10% of total equity allocation, with a high risk tolerance and a stated willingness to ride out multi-quarter factor drawdowns. The fund is also relevant for advisers building explicit factor mandates that include momentum and earnings-growth tilts.

Avoid if: Investors with a strict cap-weighted S&P 500 or S&P 500 growth benchmark mandate, given that the AlphaDEX methodology produces tracking error by design. Short-horizon traders, capital-preservation investors, and anyone unable to tolerate a drawdown of 20% to 30% in a value-rotation scenario should not hold this fund. Investors who already have substantial growth-factor exposure through other holdings should also avoid doubling up on the same underlying risk.

Recommendation

BLOCKED - methodology gate failed (frameworkRuleCheck). The model score is 59/100 (OPPORTUNISTIC BUY), but this is not an actionable recommendation until the gate is verified.

Entry levels under review.

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Fund price, holdings and quote data sourced from Yahoo Finance and ETF.com; press coverage of the May 2026 new 12-month high from Daily Political; aggregator coverage of the WIN Advisors holdings-change filing from The Motley Fool; and MarketBeat price and holdings summary.

Primary source types: SEC-filed holdings-change disclosures referenced by aggregator coverage; the fund's summary prospectus and official methodology description hosted by Yahoo Finance and ETF.com; and third-party ETF research and commentary drawn from MarketBeat and ETF.com product pages.

Key sources

• First Trust Large Cap Growth AlphaDEX Fund (FTC) Earnings Report Date - NASDAQ.com
• First Trust Large Cap Growth AlphaDEX Fund (FTC) 10-K Report: Annual Filing Summary & Key Insights - Financhill
• FTC Quote - First Trust Large Cap Growth AlphaDEX Fund - Bloomberg
• FTC First Trust Large Cap Growth AlphaDEX Fund
• First Trust Large Cap Growth AlphaDEX Fund (FTC) Stock Price, News, Quote & History - Yahoo Finance
• FTC: First Trust Large Cap Growth AlphaDEX Fund - Stock Price, Quote and News - CNBC
• First Trust Large Cap Growth AlphaDEX? Fund (FTC)
• First Trust Large Cap Growth AlphaDEX? Fund ETF Forecast: up to $202.79! - FTC ETF Price Prediction, Long-Term & Short-Term Share Revenue Pr

Data correct as of 2026-08-08